Search for genetic factors associated with sleep and circadian rhythm disorders

寻找与睡眠和昼夜节律紊乱相关的遗传因素

基本信息

  • 批准号:
    12672198
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Sleep and circadian rhythm disorders are thought to be multifactorial disordes involving various genetic and environmental factors. In this study, we investigated narcolepsy as a sleep disorder and delayed sleep phase syndrome (DSPS) and non-24-hour sleep wake syndrome (Non-24) as circadian rhythm disorders, and attempted to find genetic factors (genes) predisposing to these disorders. Gene association study was carried out using nucleotide variations in candidate genes for predisposing to the disorders as markers. Briefly, to search for nucleotide changes in such candidate genes, variation screening was carried out by means of PCR-SSCP and PCR-direct sequencing, and resultant nucleotide changes were used as markers in genotyping of the cases and controls. Using the typing data, we examined if there were any associations between the disorders and candidate genes investigated. The results in this study indicate that there is a significant association between human narcolepsy and either … More tumor necrosis factor-alpha (TNF-α) or TNF-α receptor 2 (TNFR2) gene, suggesting that the TNF-α-TNFR2 signal-transduction pathway could participate in the pathogenesis and pathophysiology of human narcolepsy. We further demonstrated that the ubiquitous transcription factor OCT-1 could bind to the functional single nucleotide polymorphism Q3NP) sites in the TNF-α gene promoter in an allele-specific manner. This suggest the possibility that the TNF-αexpression level modulated by the allelespecific binding of OCT-1 to such functional SNP sites could influence the predisposition to human narcolepsy. Another finding to note in this study is that the human leukocyte antigen (HLA) haplotype carrying DRB1^*1502-DQB1^*0601 has a negative association with human narcolepsy. This leads to the hypothesis that the haplotype could confer protection against narcolepsy.As for the genetic factors predisposing to DSPS and Non-24, we have so far investigated c-Fos and N-acetyltransferase (NAT2) genes without association with the disorder. Further studies are required. Less
睡眠和昼夜节律紊乱被认为是涉及各种遗传和环境因素的多因素紊乱。在这项研究中,我们调查了作为睡眠障碍的发作性睡病和作为昼夜节律障碍的睡眠时相延迟综合征(DSPS)和非24小时睡眠觉醒综合征(Non-24),并试图找到这些疾病的遗传因素(基因)。基因关联研究是利用易感基因中的核苷酸变异作为标记进行的。简言之,为了寻找这些候选基因中的核苷酸变化,通过PCR-SSCP和PCR直接测序进行变异筛选,并将所得核苷酸变化用作病例和对照的基因分型的标记。使用分型数据,我们检查了疾病和候选基因之间是否存在任何关联。这项研究的结果表明,人类嗜睡症与以下两者之间存在显著关联: ...更多信息 肿瘤坏死因子-α(TNF-α)或肿瘤坏死因子-α受体2(TNFR 2)基因,提示TNF-α-TNFR 2信号转导通路可能参与了人类发作性睡病的发病机制和病理生理过程。我们进一步证明了普遍存在的转录因子OCT-1可以以等位基因特异性的方式与TNF-α基因启动子中的功能性单核苷酸多态性位点(Q3 NP)结合。这表明OCT-1与这些功能性SNP位点的等位基因特异性结合调节的TNF-α表达水平可能影响人类嗜睡症的易感性。本研究中另一个值得注意的发现是,携带DRB 1 ^*1502-DQB 1 ^*0601的人类白细胞抗原(HLA)单倍型与人类嗜睡症呈负相关。至于易感DSPS和Non-24的遗传因素,迄今为止,我们已经研究了c-Fos和N-乙酰转移酶(NAT 2)基因,但与疾病无关。需要进一步研究。少

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Miyagawa T, et al.: "Identification of a telomeric boundary of the HLA region with potential for predisposition to human narcolepsy"Immunogenetics. 52. 12-18 (2000)
Miyakawa T 等人:“HLA 区域端粒边界的识别,可能易患人类嗜睡病”免疫遗传学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Shishikura,H.Hohjoh,と,Tokunaga: "Novel allele containing a 190 (C→T) nonsynonymous substitution in the N-acetyltransferase (NAT2) gene"Human Mutation. 15. 581-581 (2000)
K.Shishikura、H.Hohjoh 和 Tokunaga:“N-乙酰转移酶 (NAT2) 基因中含有 190 (C→T) 非同义取代的新型等位基因”人类突变。15. 581-581 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Kawashima et al.: "Association studies y the tumor necrosis factor-alpha (TNFA) and its receptor I (TNFR1)"Korean J. Genetics. 23. 365-370 (2001)
M.Kawashima 等人:“肿瘤坏死因子-α (TNFA) 及其受体 I (TNFR1) 的关联研究”Korean J. Genetics。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hohjoh H, et al.: "Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy"Tissue Antigens. 56. 446-448 (2000)
Hohjoh H 等人:“肿瘤坏死因子受体 2 (TNFR2) 基因与人类发作性睡病的显着关联”组织抗原。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Hohjoh, K. Tokunaga: "Allele-specidic binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide .."Genes and Immunity. 2. 105-109 (2001)
H.Hohjoh、K. Tokunaga:“普遍存在的转录因子 OCT-1 与功能性单核苷酸的等位基因特异性结合……”基因与免疫。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOHJOH Hirohiko其他文献

HOHJOH Hirohiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOHJOH Hirohiko', 18)}}的其他基金

Establishment of a novel RNAi knockdown targeting nucleotide variations in neurodegenerative disease-causing alleles.
建立针对神经退行性疾病引起的等位基因中核苷酸变异的新型 RNAi 敲除。
  • 批准号:
    20390251
  • 财政年份:
    2008
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Phylogenetic analyses of the HLA-DRB1 gene based on the DR haplotypes
基于 DR 单倍型的 HLA-DRB1 基因的系统发育分析
  • 批准号:
    14340237
  • 财政年份:
    2002
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders.
利用人类遗传学克服复杂的诊断挑战,评估泛祖多基因评分以减少发作性睡病和昼夜节律睡眠觉醒障碍的误诊。
  • 批准号:
    10576448
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Dopamine circuit control of wakefulness in health and sleepiness in narcolepsy
多巴胺回路控制健康时的清醒和嗜睡症时的嗜睡
  • 批准号:
    461591
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
Pandemrix and T Cell Immunology in Narcolepsy
Pandemrix 和 T 细胞免疫学在发作性睡病中的应用
  • 批准号:
    10405047
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Pandemrix and T Cell Immunology in Narcolepsy
Pandemrix 和 T 细胞免疫学在发作性睡病中的应用
  • 批准号:
    10618986
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Narcolepsy with cataplexy: a brain orexin replacement strategy
发作性睡病伴猝倒:大脑食欲素替代策略
  • 批准号:
    nhmrc : 2003370
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Ideas Grants
Early-onset narcolepsy: A role for histamine
早发性嗜睡症:组胺的作用
  • 批准号:
    9906984
  • 财政年份:
    2020
  • 资助金额:
    $ 2.18万
  • 项目类别:
Diagnostic delay in narcolepsy: healthcare problems to be solved for its early diagnosis
发作性睡病的诊断延迟:早期诊断需解决的医疗保健问题
  • 批准号:
    20K10423
  • 财政年份:
    2020
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Differentiating Narcolepsy from Sleep Deprivation Syndrome with a Physiological Approach Applying Time-Frequency Analysis
应用时频分析的生理学方法区分发作性睡病和睡眠剥夺综合征
  • 批准号:
    20K15886
  • 财政年份:
    2020
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Disrupted Nighttime Sleep (DNS) in Pediatric Narcolepsy
小儿发作性睡病的夜间睡眠 (DNS) 中断
  • 批准号:
    10155593
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
Mind-Body Approach to Improve Health- Related Quality of Life for People with Narcolepsy: A Feasibility Study
改善发作性睡病患者健康相关生活质量的身心方法:可行性研究
  • 批准号:
    10237141
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了